23 May 2013
Keywords: phase, iii, betafectin, results, 4th, qtr, alpha-beta
Article | 12 June 1995
Alpha-Beta has begun its Phase III pivotal trial of Betafectin
(recombinant beta glucan) to prevent surgical infections, and
anticipates that ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 June 1995
© 2013 thepharmaletter.com